Cargando…

Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”

Detalles Bibliográficos
Autor principal:	Le Panse, Rozen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320298/ https://www.ncbi.nlm.nih.gov/pubmed/28271070 http://dx.doi.org/10.1155/2017/6950308

Ejemplares similares

Response to: Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017)

Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis
por: Cao, Yuze, et al.
Publicado: (2015)

Role of miRNAs in Normal and Myasthenia Gravis Thymus
por: Cron, Mélanie A., et al.
Publicado: (2020)

Corrigendum to “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017)

Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
por: Punga, Tanel, et al.
Publicado: (2014)

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
por: Behin, Anthony, et al.
Publicado: (2018)

Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

The Muscle Is Not a Passive Target in Myasthenia Gravis
por: Vilquin, Jean-Thomas, et al.
Publicado: (2019)

Myasthenia gravis: A challenge
por: Ramesh, Bhagyalakshmi
Publicado: (2015)

Subgroup Classification of Myasthenia Gravis
por: Renjen, Pushpendra N.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
por: Sabre, Liis, et al.
Publicado: (2020)

Identifying a Polymorphic ‘Switch’ That Influences miRNAs' Regulation of a Myasthenia Gravis Risk Pathway
por: Yang, Lili, et al.
Publicado: (2014)

Nephrotic syndrome after thymectomy for myasthenia gravis
por: Kute, V. B., et al.
Publicado: (2013)

The perianaesthetic management of a patient with myasthenia gravis
por: Singh, Anisha, et al.
Publicado: (2023)

Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
por: Cron, Mélanie A., et al.
Publicado: (2019)

Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
por: Cron, Mélanie A., et al.
Publicado: (2020)

Management of thoracoscopic thymectomy in a myasthenia gravis patient
por: Adate, Kavita, et al.
Publicado: (2011)

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients
por: Nogales-Gadea, Gisela, et al.
Publicado: (2014)

Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.
por: Galassi, Giuliana, et al.
Publicado: (2021)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Regulatory B cells in myasthenia gravis are differentially affected by therapies
por: Yilmaz, Vuslat, et al.
Publicado: (2018)

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
por: Yevgi, Recep, et al.
Publicado: (2021)

New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022)

Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression
por: Zhang, Yunpeng, et al.
Publicado: (2016)

Sweet taste loss in myasthenia gravis: more than a coincidence?
por: Chabwine, Joelle N, et al.
Publicado: (2014)

Myasthenia Gravis Associated with Acute Hepatitis E Infection in Immunocompetent Woman
por: Belbezier, Aude, et al.
Publicado: (2014)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

Electronic health record derived-impact of COVID-19 on myasthenia gravis
por: Roy, Bhaskar, et al.
Publicado: (2021)

Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'
por: Shin, Vivian Y, et al.
Publicado: (2016)

Comment on “Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer”
por: Jayaraj, Rama, et al.
Publicado: (2018)

Profound Olfactory Dysfunction in Myasthenia Gravis
por: Leon-Sarmiento, Fidias E., et al.
Publicado: (2012)

Emergency cesarian section in a patient of myasthenia gravis: Is neuraxial anesthesia safe?
por: Mundada, Surbhi D., et al.
Publicado: (2012)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature
por: Aryani, Omid, et al.
Publicado: (2017)

Clinical characteristics and outcomes of patients with overlapping Miller Fisher syndrome and myasthenia gravis
por: Yuan, Jun-Liang, et al.
Publicado: (2019)

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links
por: Singh, Shalendra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40521of25iupev00m40jn74rqt